Vaccine adjuvants
AssigneeCadila Pharmaceuticals Ltd.
InventorsBakulesh Mafatlal Khamar, Rajiv Indravadan Modi, Indravadan Ambalal Modi, Prasanta Kumar Ghosh, Nirav Desai
Life of this patent
Estimating the term…
Loading patent…
AssigneeCadila Pharmaceuticals Ltd.
InventorsBakulesh Mafatlal Khamar, Rajiv Indravadan Modi, Indravadan Ambalal Modi, Prasanta Kumar Ghosh, Nirav Desai
Estimating the term…
The invention relates to a novel adjuvant Mycobacterium w and or its constituents and adjuvant containing composition, which contains antigen(s) with pharmaceutical acceptable carrier and its uses. Mycobacterium w and or its constituents when administered with antigen(s) to mammal results in enhanced immunogenicity of antigen. The enhanced immunogenicity manifests as humoral responses as well as cell mediated immunity. The adjuvant effect is seen with variety of antigens in various mammals irrespective of their immune status at the time of administration of Mycobacterium w and antigen containing composition. e.g. immune naïve or preimmunized status.
A method for generating an immune response against an antigen by administration of a pharmaceutical composition comprising said antigen and Mycobacterium w and/or constituents thereof as an adjuvant.
Dependencies are inferred from the claim text.